Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Lorne Hopfner currently holds 4,026 shares of Inozyme Pharma, Inc. (INZY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Lorne Hopfner has been a net buyer of INZY stock. They have purchased $25.2M and sold $22.0M worth of shares.
Robert Lorne Hopfner's most recent insider trade was on Dec 19, 2025, when they purchased 1,000 shares at $17.35 per share.
Robert Lorne Hopfner serves as Executive at Inozyme Pharma, Inc. (INZY). They have executed 65 insider transactions totaling $47.3M over their tenure at the company.
Robert Lorne Hopfner holds the position of Executive at Inozyme Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Robert Lorne Hopfner has shown a buying trading pattern, with $25.2M in total purchases and $22.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Lorne Hopfner was on Jul 1, 2025, when they sold $11.7M worth of INZY shares. This transaction involved 2,923,110 shares at $4.00 per share.
Robert Lorne Hopfner currently owns 4,026 shares of Inozyme Pharma, Inc. (INZY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Lorne Hopfner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Lorne Hopfner has 65 Form 4 filings on record as an insider at Inozyme Pharma, Inc..
Set alerts for Robert Lorne Hopfner and 40,000+ other insiders.